147 related articles for article (PubMed ID: 27876619)
41. Transforming growth factor-beta in the red nucleus plays antinociceptive effect under physiological and pathological pain conditions.
Wang J; Yu J; Ding CP; Han SP; Zeng XY; Wang JY
Neuroscience; 2015 Apr; 291():37-45. PubMed ID: 25662509
[TBL] [Abstract][Full Text] [Related]
42. Gabapentin decreases microglial cells and reverses bilateral hyperalgesia and allodynia in rats with chronic myositis.
Rosa AS; Freitas MF; Rocha IR; Chacur M
Eur J Pharmacol; 2017 Mar; 799():111-117. PubMed ID: 28192096
[TBL] [Abstract][Full Text] [Related]
43. The heart-rate-reducing agent, ivabradine, reduces mechanical allodynia in a rodent model of neuropathic pain.
Noh S; Kumar N; Bukhanova N; Chen Y; Stemkowsi PL; Smith PA
Eur J Pain; 2014 Sep; 18(8):1139-47. PubMed ID: 24677354
[TBL] [Abstract][Full Text] [Related]
44. Duloxetine Inhibits Microglial P2X4 Receptor Function and Alleviates Neuropathic Pain after Peripheral Nerve Injury.
Yamashita T; Yamamoto S; Zhang J; Kometani M; Tomiyama D; Kohno K; Tozaki-Saitoh H; Inoue K; Tsuda M
PLoS One; 2016; 11(10):e0165189. PubMed ID: 27768754
[TBL] [Abstract][Full Text] [Related]
45. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury.
Tsuda M; Shigemoto-Mogami Y; Koizumi S; Mizokoshi A; Kohsaka S; Salter MW; Inoue K
Nature; 2003 Aug; 424(6950):778-83. PubMed ID: 12917686
[TBL] [Abstract][Full Text] [Related]
46. Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression.
Burke NN; Kerr DM; Moriarty O; Finn DP; Roche M
Brain Behav Immun; 2014 Nov; 42():147-56. PubMed ID: 24994592
[TBL] [Abstract][Full Text] [Related]
47. KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.
Grimaldi A; D'Alessandro G; Golia MT; Grössinger EM; Di Angelantonio S; Ragozzino D; Santoro A; Esposito V; Wulff H; Catalano M; Limatola C
Cell Death Dis; 2016 Apr; 7(4):e2174. PubMed ID: 27054329
[TBL] [Abstract][Full Text] [Related]
48. A new model of nerve injury in the rat reveals a role of Regulator of G protein Signaling 4 in tactile hypersensitivity.
Taccola G; Doyen PJ; Damblon J; Dingu N; Ballarin B; Steyaert A; Rieux AD; Forget P; Hermans E; Bosier B; Deumens R
Exp Neurol; 2016 Dec; 286():1-11. PubMed ID: 27641322
[TBL] [Abstract][Full Text] [Related]
49. P2X7 receptor in the trigeminal sensory nuclear complex contributes to tactile allodynia/hyperalgesia following trigeminal nerve injury.
Ito G; Suekawa Y; Watanabe M; Takahashi K; Inubushi T; Murasaki K; Hirose N; Hiyama S; Uchida T; Tanne K
Eur J Pain; 2013 Feb; 17(2):185-99. PubMed ID: 22865777
[TBL] [Abstract][Full Text] [Related]
50. Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair.
Girault A; Chebli J; Privé A; Trinh NT; Maillé E; Grygorczyk R; Brochiero E
Respir Res; 2015 Sep; 16(1):100. PubMed ID: 26335442
[TBL] [Abstract][Full Text] [Related]
51. Chronological changes of mechanical allodynia and spinal microglia activation by an intrathecal injection of MK-801.
Kim MA; Jeong KY
Neuroreport; 2013 Aug; 24(11):585-9. PubMed ID: 23752344
[TBL] [Abstract][Full Text] [Related]
52. Minocycline attenuates mechanical allodynia and central sensitization following peripheral second-degree burn injury.
Chang YW; Waxman SG
J Pain; 2010 Nov; 11(11):1146-54. PubMed ID: 20418178
[TBL] [Abstract][Full Text] [Related]
53. Eugenol reverses mechanical allodynia after peripheral nerve injury by inhibiting hyperpolarization-activated cyclic nucleotide-gated (HCN) channels.
Yeon KY; Chung G; Kim YH; Hwang JH; Davies AJ; Park MK; Ahn DK; Kim JS; Jung SJ; Oh SB
Pain; 2011 Sep; 152(9):2108-2116. PubMed ID: 21664051
[TBL] [Abstract][Full Text] [Related]
54. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
Chen YJ; Nguyen HM; Maezawa I; Grössinger EM; Garing AL; Köhler R; Jin LW; Wulff H
J Cereb Blood Flow Metab; 2016 Dec; 36(12):2146-2161. PubMed ID: 26661208
[TBL] [Abstract][Full Text] [Related]
55. CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury.
Saika F; Kiguchi N; Kobayashi Y; Fukazawa Y; Kishioka S
Eur J Pain; 2012 Oct; 16(9):1271-80. PubMed ID: 22528550
[TBL] [Abstract][Full Text] [Related]
56. Ca2+ -activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis.
Lin H; Zheng C; Li J; Yang C; Hu L
Int Immunopharmacol; 2014 Dec; 23(2):642-8. PubMed ID: 25466273
[TBL] [Abstract][Full Text] [Related]
57. Chronic pain and microglia: the role of ATP.
Inoue K; Tsuda M; Koizumi S
Novartis Found Symp; 2004; 261():55-64; discussion 64-7, 149-54. PubMed ID: 15469044
[TBL] [Abstract][Full Text] [Related]
58. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
[TBL] [Abstract][Full Text] [Related]
59. Effect of the KCa3.1 blocker, senicapoc, on cerebral edema and cardiovascular function after cardiac arrest - A randomized experimental rat study.
Hansen FB; Secher N; Mattson T; Løfgren B; Simonsen U; Granfeldt A
Resusc Plus; 2021 Jun; 6():100111. PubMed ID: 34223371
[TBL] [Abstract][Full Text] [Related]
60. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators.
Jenkins DP; Yu W; Brown BM; Løjkner LD; Wulff H
Assay Drug Dev Technol; 2013; 11(9-10):551-60. PubMed ID: 24351043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
